BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 37810864)

  • 1. Treatment of
    Gupta A; Shetty S; Mutalik S; Chandrashekar H R; K N; Mathew EM; Jha A; Mishra B; Rajpurohit S; Ravi G; Saha M; Moorkoth S
    Heliyon; 2023 Oct; 9(10):e20406. PubMed ID: 37810864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical issues in the pathophysiology and management of peptic ulcer disease.
    Hunt RH; Malfertheiner P; Yeomans ND; Hawkey CJ; Howden CW
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):685-99. PubMed ID: 8590166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.
    Malfertheiner P; Mégraud F; O'Morain C; Hungin AP; Jones R; Axon A; Graham DY; Tytgat G;
    Aliment Pharmacol Ther; 2002 Feb; 16(2):167-80. PubMed ID: 11860399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia.
    Gisbert JP; Marcos S; Gisbert JL; Pajares JM
    Eur J Gastroenterol Hepatol; 2001 Nov; 13(11):1303-7. PubMed ID: 11692055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful eradication of Helicobacter pylori prevents relapse of peptic ulcer disease.
    Tomita T; Fukuda Y; Tamura K; Tanaka J; Hida N; Kosaka T; Hori K; Sakagami T; Satomi M; Shimoyama T
    Aliment Pharmacol Ther; 2002 Apr; 16 Suppl 2():204-9. PubMed ID: 11966543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Peptic ulcer disease and H. pylori gastritis: key advances in clinical management].
    Schneider C; Venerito M
    Dtsch Med Wochenschr; 2022 Sep; 147(17):1103-1108. PubMed ID: 36030782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No Helicobacter pylori, no Helicobacter pylori-associated peptic ulcer disease.
    Tytgat GN
    Aliment Pharmacol Ther; 1995; 9 Suppl 1():39-42. PubMed ID: 7495941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Helicobacter pylori eradication therapy in Korea].
    Kim SY; Jung SW
    Korean J Gastroenterol; 2011 Dec; 58(2):67-73. PubMed ID: 21873820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Helicobacter pylori-related diseases: dyspepsia, ulcer and gastric cancer].
    Gisbert JP
    Gastroenterol Hepatol; 2008 Oct; 31 Suppl 4():18-28. PubMed ID: 19434862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori: A Review of Current Diagnostic and Management Strategies.
    Guevara B; Cogdill AG
    Dig Dis Sci; 2020 Jul; 65(7):1917-1931. PubMed ID: 32170476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic treatment for Helicobacter pylori: Is the end coming?
    Kim SY; Choi DJ; Chung JW
    World J Gastrointest Pharmacol Ther; 2015 Nov; 6(4):183-98. PubMed ID: 26558152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Helicobacter pylori in peptic ulcer and gastric cancer].
    Matsukura N; Onda M; Yamashita K
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):169-78. PubMed ID: 7857088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Helicobacter pylori-related diseases].
    Gisbert JP
    Gastroenterol Hepatol; 2013 Oct; 36 Suppl 2():39-50. PubMed ID: 24160951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
    Hong EJ; Park DI; Oh SJ; Song MJ; Choi WH; Hong CH; Park JH; Kim HJ; Cho YK; Shon CI; Jeon WK; Kim BI
    Korean J Gastroenterol; 2008 Aug; 52(2):80-5. PubMed ID: 19077498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori-associated peptic ulcer disease in older patients: current management strategies.
    Pilotto A
    Drugs Aging; 2001; 18(7):487-94. PubMed ID: 11482742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of H2-receptor antagonist- and proton-pump inhibitor-based triple regimens for the eradication of Helicobacter pylori in Chinese patients with gastritis or peptic ulcer.
    Hu FL; Jia JC; Li YL; Yang GB
    J Int Med Res; 2003; 31(6):469-74. PubMed ID: 14708410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
    Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.